Navigation Links
d'Gianni to Unveil Exquisite New Lingerie Collection Aboard New York City Cruise Ship
Date:7/27/2009

NEW YORK, July 27 /PRNewswire/ -- d'Gianni Lingerie (www.dgianni.com) is unveiling its sensual Intimate Apparel Collection aboard a luxury liner in New York City on August 22, 2009 from 7:00 p.m. to 10:00 p.m. Boarding time is 6:30 p.m. and the cruise ship sets sail from New York City's 23rd Street dock on the East River for three exciting hours of fine dining, entertainment and the chance to view the newest d'Gianni brands during the fashion show. Tickets are going for a minimum donation of $100.00, with ten percent of all proceeds benefitting The Breast Cancer Research Foundation's (www.bcrfcure.org) battle against breast cancer.

"I'm so pleased to be launching our newest d'Gianni line of lingerie," says co-founder of d'Gianni. "The new collection is simply exquisite. Every single piece evokes a certain attitude, perception and frame of mind."

The evening voyage around New York City will reveal the intimate details of d'Gianni's latest line of sexy lingerie designed to inspire women to embrace their inner sensuality and beauty. Each piece of the collection is tailored to fit a specific size and shape of body. The star-studded audience will get the chance to match their own personalities to the lingerie with which they feel a connection.

Both founders of d'Gianni united almost a decade ago with a goal to establish a lingerie brand name with one vision in mind: to enhance sensuality in the bedroom. d'Gianni continues to launch innovative products designed to accentuate the sensuality and beauty of a variety of shapes and sizes.

Tickets for the luxurious cruise are available through the d'Gianni website, http://www.dgianni.com/cruise.aspx, or by calling 917-470-9883. To inquire about sponsorship opportunities for the August 22nd event as well as others that may be upcoming, please call 201-360-3904.

About d'Gianni

d'Gianni was established in January 2000 by a man and a woman whose different personalities converged on one single vision . . . to enhance sensuality in the bedroom. For nine years, d'Gianni has been inspiring people to shed their inhibitions and rid themselves of all their insecurities when it comes to their bodies. The company further hopes to help its clients erase the standard notion of beauty that time and again, society has impressed upon us. So be happy. Be proud. Honor the body you are blessed with. For more information about d'Gianni please visit www.dGianni.com.

About The Breast Cancer Research Foundation

The Breast Cancer Research Foundation(R) was founded in 1993 by Evelyn H. Lauder as an independent, not-for-profit organization dedicated to funding innovative clinical and translational research. The Foundation supports scientists at top universities and academic medical centers worldwide conducting the most advanced and promising breast cancer research that will help lead to prevention and a cure in our lifetime. A minimum of 85 cents of each dollar donated to the Foundation goes directly to breast cancer research and awareness programs. For more information about BCRF, visit www.bcrfcure.org.


'/>"/>
SOURCE d'Gianni Lingerie; The Breast Cancer Research Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lilly to Unveil More Than 30 Studies at Premier Lung Cancer Meeting
2. AlphaRx Unveils its China Strategy
3. Explorers Bounty Unveils New Line of Tribal Stone Crackers
4. "Aprima Medical Software, Inc.," Unveiled by iMedica; Premier EHR / PM Company Adopts New Name
5. Aprima Medical Software, Inc., Unveiled by iMedica; Premier EHR / PM Company Adopts New Name
6. U.S. Unveils Stricter Food-Safety Standards
7. Video: Perot Systems Unveils Series of Healthcare Video Case Studies
8. Furniture Online's New Look Unveiled
9. Jarrow Formulas, Inc. to Unveil Children's Natural Health Products at Upcoming Natural MarketPlace 2009 Show in Las Vegas
10. Sparta Systems Unveils TrackWise(R) Clinical Quality Management Solution
11. HealthLeaders-InterStudy Unveils Enhanced Employer Vantage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and ... drug safety and minimize the cost of development. In this webinar, sponsored by ... cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , ...
(Date:4/28/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a ... does not. Yisrayl says with so many titles and names for the Creator, it’s ... with a little Scripture, backed with a lot of research, the truth is undeniable. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions announced the ... implement a Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software ... in long-term care, Brooke Grove now has the capability to achieve its goal ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different ... purpose as the host of the “Informed” series. The program focuses on many important ... series focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt University ... first patients in Nashville , Tennesse ... Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. ... to provide long-term reflux control by restoring normal function ... nearly 65 million people in the United ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology: